These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 15856526)
1. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526 [TBL] [Abstract][Full Text] [Related]
2. Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box. Coulson JM; Edgson JL; Marshall-Jones ZV; Mulgrew R; Quinn JP; Woll PJ Biochem J; 2003 Feb; 369(Pt 3):549-61. PubMed ID: 12403649 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2. Khattar NH; Lele SM; Kaetzel CS J Biomed Sci; 2005; 12(1):65-77. PubMed ID: 15864740 [TBL] [Abstract][Full Text] [Related]
4. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
6. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304 [TBL] [Abstract][Full Text] [Related]
7. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
8. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer. Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
10. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. Boelens MC; van den Berg A; Vogelzang I; Wesseling J; Postma DS; Timens W; Groen HJ J Clin Pathol; 2007 Jun; 60(6):608-14. PubMed ID: 16489176 [TBL] [Abstract][Full Text] [Related]
11. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153 [TBL] [Abstract][Full Text] [Related]
12. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775 [TBL] [Abstract][Full Text] [Related]
13. Loss of USF transcriptional activity in breast cancer cell lines. Ismail PM; Lu T; Sawadogo M Oncogene; 1999 Sep; 18(40):5582-91. PubMed ID: 10523835 [TBL] [Abstract][Full Text] [Related]
14. Does c-erbB-2 play a role in the first steps of lung carcinogenesis? Meert AP; Martin B; Verdebout JM; Ninane V; Sculier JP Anticancer Res; 2005; 25(3B):2005-8. PubMed ID: 16158937 [TBL] [Abstract][Full Text] [Related]
15. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412 [TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054 [TBL] [Abstract][Full Text] [Related]
17. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138 [TBL] [Abstract][Full Text] [Related]
18. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]. Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209 [TBL] [Abstract][Full Text] [Related]
19. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Eymin B; Gazzeri S; Brambilla C; Brambilla E Oncogene; 2001 Mar; 20(14):1678-87. PubMed ID: 11313916 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer. Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]